Longitudinal Characterization and Genetic Analysis of Pediatric-Onset Morphea

Overview

About this study

The purpose of this project is to determine the genetic causes of disease and establish accurate clinical indicators and biomarkers of disease activity with an overall goal of improving care for patients with morphea.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of morphea by a pediatric dermatologist or rheumatologist
  • Patients may be any age at the time of entry, though disease onset must be before 18-years-old

Exclusion Criteria:

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Megha Tollefson, M.D.

Closed for enrollment

Contact information:

Lauren Schimek M.H.A., CCRP

(507)538-8142

Schimek.Lauren@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20309703

Mayo Clinic Footer